BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8179582)

  • 1. Identification of an HIV-1 Nef peptide that binds to HLA class II antigens.
    Torres BA; Johnson HM
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1059-65. PubMed ID: 8179582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Nef-induced CD4 T cell proliferation.
    Torres BA; Tanabe T; Johnson HM
    Biochem Biophys Res Commun; 1996 Aug; 225(1):54-61. PubMed ID: 8769094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-binding regions of HIV-1 proteins. I. Detection of seven HLA binding regions in the HIV-1 Nef protein.
    Choppin J; Martinon F; Connan F; Gomard E; Levy JP
    J Immunol; 1991 Jul; 147(2):569-74. PubMed ID: 1712811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of interleukin-2 and interferon-gamma by an HIV-1 Nef-encoded synthetic peptide.
    Haraguchi S; Cianciolo GJ; Good RA; James-Yarish M; Brigino E; Day NK
    AIDS; 1998 May; 12(7):820-3. PubMed ID: 9619818
    [No Abstract]   [Full Text] [Related]  

  • 6. Mapping of multiple binding domains of the superantigen staphylococcal enterotoxin A for HLA.
    Griggs ND; Pontzer CH; Jarpe MA; Johnson HM
    J Immunol; 1992 Apr; 148(8):2516-21. PubMed ID: 1560207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules.
    Soos JM; Johnson HM
    Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ribozyme target site located in the HIV-1 nef open reading frame.
    Larsson S; Hotchkiss G; Su J; Kebede T; Andäng M; Nyholm T; Johansson B; Sönnerborg A; Vahlne A; Britton S; Ahrlund-Richter L
    Virology; 1996 May; 219(1):161-9. PubMed ID: 8623525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation.
    Pizzato N; Derrien M; Lenfant F
    Hum Immunol; 2004 Nov; 65(11):1389-96. PubMed ID: 15556689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature-sensitive for CD4 downregulation.
    Aiken C; Krause L; Chen YL; Trono D
    Virology; 1996 Mar; 217(1):293-300. PubMed ID: 8599214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells.
    Niederman TM; Hastings WR; Luria S; Bandres JC; Ratner L
    Virology; 1993 May; 194(1):338-44. PubMed ID: 8480425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.
    Brown A; Gartner S; Kawano T; Benoit N; Cheng-Mayer C
    J Leukoc Biol; 2005 Sep; 78(3):675-85. PubMed ID: 16000390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR.
    Grzesiek S; Stahl SJ; Wingfield PT; Bax A
    Biochemistry; 1996 Aug; 35(32):10256-61. PubMed ID: 8756680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV.
    Linnemann T; Zheng YH; Mandic R; Peterlin BM
    Virology; 2002 Mar; 294(2):246-55. PubMed ID: 12009866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.
    Giese SI; Woerz I; Homann S; Tibroni N; Geyer M; Fackler OT
    Virology; 2006 Nov; 355(2):175-91. PubMed ID: 16916529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist properties of a microbial superantigen peptide.
    Pontzer CH; Griggs ND; Johnson HM
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1191-7. PubMed ID: 8323541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239open.
    Foster JL; Anderson SJ; Frazier AL; Garcia JV
    Virology; 1994 Jun; 201(2):373-9. PubMed ID: 8184546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of HIV-1 clones chimeric for subtypes B and C nef.
    Jere A; Piroozmand A; Tripathy S; Paranjape R; Sakurai A; Fujita M; Adachi A
    Int J Mol Med; 2004 Dec; 14(6):1087-90. PubMed ID: 15547679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV encodes for its own CD4 T-cell superantigen mitogen.
    Torres BA; Tanabe T; Yamamoto JK; Johnson HM
    Biochem Biophys Res Commun; 1996 Aug; 225(2):672-8. PubMed ID: 8753817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression.
    Ali A; Ng HL; Dagarag MD; Yang OO
    Eur J Immunol; 2005 Nov; 35(11):3221-8. PubMed ID: 16206233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.